Japan Specialist

Mark Chadwick

Over 20 years experience in equities and asset management in Asia and Japan. Qualified CFA with experience analyzing companies as a buy-side analyst. In-depth knowledge of company fundamental analysis, corporate governance and valuations.

Eiken Chemical (4549) | Activists, Alchemy, and the Pursuit of Profit

Consolidation in the Med-Tech Sector? Eiken and Hogy to Benefit

Thematic (Sector/Industry)

Japan Consumer discretionary / Thematic (Sector/Industry)

<ul>
<li>The broader Topix index declined by 1.6% on the week, but remains up 17% year-to-date.</li>
<li>Shares in Koito rose 26% after the company unveiled a new MTP and a substantial ¥50 billion stock buyback program.</li>
<li>We believe that the med-tech space is worth watching. Nippon Active Value, Asset Value Investors and ValueAct are all now involved in the space. </li>
</ul>


The broader Topix index declined by 1.6% on the week, but remains up 17% year-to-date.
Shares in Koito rose 26% after the company unveiled a new MTP and a substantial ¥50 billion stock buyback program.
We believe that the med-tech space is worth watching. Nippon Active Value, Asset Value Investors and ValueAct are all now involved in the space. 


Japan Weekly | Stocks Take a Break After Rising +17% in Q1